HF
IOVA icon

HRT Financial’s Iovance Biotherapeutics IOVA Stock Holding History

HRT Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
3,486,299
-869,711
-20% -$2.78M 0.03% 541
2025
Q4 		$11.9M Buy
4,356,010
+3,986,314
+1,078% +$9.22M 0.04% 386
2025
Q3 		$802K Buy
369,696
+301,434
+442% +$712K ﹤0.01% 1637
2025
Q2 		$117K Sell
68,262
-292,480
-81% -$728K ﹤0.01% 2181
2025
Q1 		$1.2M Buy
+360,742
New +$1.86M 0.01% 1041
2024
Q3 		– Sell
-70,967
Closed -$569K – 2767
2024
Q2 		$569K Sell
70,967
-225,207
-76% -$2.41M ﹤0.01% 1236
2024
Q1 		$4.39M Buy
296,174
+1,411
+0.5% +$16.4K 0.03% 297
2023
Q4 		$2.4M Buy
+294,763
New +$1.54M 0.02% 572
2023
Q2 		– Sell
-267,997
Closed -$1.64M – 2841
2023
Q1 		$1.64M Buy
+267,997
New +$1.85M 0.02% 701
2022
Q4 		– Sell
-139,467
Closed -$1.34M – 2782
2022
Q3 		$1.34M Buy
+139,467
New +$1.61M 0.01% 768
2022
Q2 		– Sell
-212,974
Closed -$3.55M – 3290
2022
Q1 		$3.55M Buy
212,974
+147,460
+225% +$2.28M 0.03% 392
2021
Q4 		$1.25M Sell
65,514
-6,190
-9% -$136K 0.01% 947
2021
Q3 		$1.77M Buy
+71,704
New +$1.69M 0.01% 827
2021
Q1 		– Sell
-80,965
Closed -$3.76M – 2892
2020
Q4 		$3.76M Buy
+80,965
New +$3.21M 0.08% 193
2020
Q3 		– Sell
-112,098
Closed -$3.08M – 2113
2020
Q2 		$3.08M Buy
+112,098
New +$3.69M 0.09% 234

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

HRT Financial's IOVA Position: Q1 2026 in Review

HRT Financial reduced its Iovance Biotherapeutics (IOVA) stake by 20% in Q1 2026, selling an estimated $2.78M and leaving 3,486,299 shares worth $12.2M. The position accounts for 0.03% of the portfolio, ranked #541.

HRT Financial first reported a position in IOVA in Q2 2020 and has held it in 15 quarters since. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • HRT Financial held 3,486,299 shares of Iovance Biotherapeutics worth $12.2M as of Q1 2026.
  • HRT Financial sold 869,711 Iovance Biotherapeutics shares in Q1 2026, an estimated $2.78M.
  • Iovance Biotherapeutics made up 0.03% of HRT Financial's portfolio in Q1 2026, its #541 holding.
  • HRT Financial first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 15 quarters since.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.